Related Experiment Videos
New classification and update on the quinolone antibiotics
D E King1, R Malone, S H Lilley
1East Carolina University School of Medicine, Greenville, North Carolina, USA.
American Family Physician
|May 23, 2000
Summary
Newer fluoroquinolones offer broad-spectrum activity and improved safety. A four-generation classification aids physicians in selecting the appropriate fluoroquinolone (quinolone drug) for diverse infections.
Area of Science:
- Pharmacology
- Infectious Diseases
- Drug Classification
Background:
- Fluoroquinolones are a class of antibiotics known for broad-spectrum bactericidal activity.
- Recent advancements have led to fluoroquinolones with enhanced antimicrobial spectra and improved pharmacokinetic profiles.
- Existing classifications may not fully capture the expanded capabilities of newer fluoroquinolone agents.
Purpose of the Study:
- To introduce and explain a new four-generation classification system for quinolone antibiotics.
- To correlate fluoroquinolone generations with their antimicrobial spectrum and clinical indications.
- To provide guidance for appropriate fluoroquinolone prescribing by family physicians.
Main Methods:
- Review of existing literature on quinolone antibiotics.
- Development of a four-generation classification based on antimicrobial spectrum and clinical use.
- Analysis of pharmacokinetic properties differentiating drugs within classes.
Main Results:
- First-generation quinolones (e.g., nalidixic acid) have limited systemic activity.
- Second-generation agents (e.g., ciprofloxacin) exhibit enhanced Gram-negative and systemic efficacy.
- Third-generation fluoroquinolones (e.g., levofloxacin) show increased activity against Gram-positive bacteria and atypical pathogens.
- Fourth-generation fluoroquinolones (e.g., trovafloxacin) provide significant activity against anaerobic bacteria.
Conclusions:
- The proposed four-generation classification effectively categorizes fluoroquinolones based on their evolving antimicrobial spectrum.
- This classification aids in understanding the expanded clinical utility of newer fluoroquinolone generations.
- The new system can assist healthcare providers, particularly family physicians, in making informed prescribing decisions for fluoroquinolone therapy.